It is hard to get excited after looking at Becton Dickinson's (NYSE:BDX) recent performance, when its stock has declined 24% over the past three months. We, however decided to study the company's ...

Medtronic is bringing on a medical device industry veteran for its new top lawyer as it prepares for a major organizational ...

Fong replaced Brad Lerman as Medtronic’s GC, who retired in 2022 before being lured out of retirement to become CLO at ...

To enable awareness and knowledge-sharing around best practices of atherothrombectomy in the treatment of vascular diseases a ...

Learn about the executive team and board of directors at Becton Dickinson & Co (BDX:XNYS) and review their bios and compensation over the latest fiscal years.

Becton Dickinson & Co Becton Dickinson & Co BDX Stock XNYS Rating as of Jul 4, 2025 Read Company Report Download PDF ...

Ivan Fong, 63, was one of the highest-proifile GCs to sign an amicus brief supporting Perkins Coie's legal challenge of ...

The "Blood Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The global blood market is poised to expand by USD 2.59 billion from 2024 to 2029, with an anticipated CAGR of 5.7%.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...